Download This Paper
Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
Rubella Immunity Across Generations: A Longitudinal Study of IgG Seroprevalence in Females (2000–2024) in Palestine
16 Pages Posted: 1 Oct 2024
More...Abstract
Background and ObjectivesRubella remains a significant public health concern, particularly for women of reproductive age due to the risk of congenital rubella syndrome (CRS). Monitoring immunity through Rubella IgG seroprevalence is essential to ensure adequate protection, particularly in regions with variable access to vaccination. This study aims to assess Rubella IgG seroprevalence among females in Palestine over a 24-year period (2000–2024), with a focus on age-specific and geographical variations in immunity. Identifying immunity gaps will provide insights into the effectiveness of vaccination programs and inform potential public health interventions.Materials and MethodsA total of 7,235 females, aged 0-59, were tested for Rubella IgG antibodies at Medicare Laboratories between 2000 and 2024. Seroprevalence was categorized into negative (<5 IU/ml), grey zone (5-10 IU/ml), and positive (>10 IU/ml). Participants were stratified by age and locality, and seroprevalence trends were analysed over time. Data were sourced from the Laboratory Information System (LIS), and statistical analyses were conducted to assess immunity levels across age groups and regions, as well as time-based trends in immunity.ResultsOverall, 89.3% of the study population tested positive for Rubella IgG, indicating strong immunity. However, 7.5% of individuals were in the grey zone, and 3.3% tested negative, highlighting potential susceptibility. The highest immunity levels were observed in women aged 20-39 years, with 89.2% testing positive. However, children aged 0-9 years had the highest proportion of negative results (19.4%), indicating gaps in early childhood vaccination. Geographically, Ramallah and Hebron demonstrated the highest immunity levels, while Bethlehem, Jerusalem, and smaller regions exhibited more grey zone and negative cases, signalling regional disparities in immunity. Immunity levels increased consistently from 2001 to 2024, though the grey zone cases also increased, indicating potential waning immunity.ConclusionRubella immunity is robust in the female population of Palestine, particularly among women of reproductive age. However, the presence of grey zone and negative results in children and certain regions highlights gaps in vaccination coverage and potential waning immunity. Targeted booster vaccination campaigns and improved adherence to the Palestinian immunization schedule are recommended to close these gaps and sustain immunity, particularly in vulnerable populations.
Keywords: Rubella, IgG seroprevalence, Palestine, immunity, vaccination, congenital rubella syndrome, public health, women of reproductive age
Suggested Citation: Suggested Citation